Corvus Pharmaceuticals (CRVS) EBT (2015 - 2026)
Corvus Pharmaceuticals' (CRVS) quarterly EBT came in at -$13.1 million in Q1 2026, down 183.23% year-on-year from $15.7 million in Q1 2025, and down 33.14% quarter-over-quarter from -$9.8 million in Q3 2025.
Corvus Pharmaceuticals (CRVS) EBT (2015 - 2026) Analysis & Trends
Corvus Pharmaceuticals' EBT history runs 12 years deep, the most recent figure standing at -$13.1 million for Q1 2026.
- On a quarterly basis, EBT fell 183.23% year-over-year to -$13.1 million in Q1 2026; TTM through Mar 2026 was -$14.8 million, a 55.71% increase from a year earlier, with the FY2025 full-year figure at -$102.1 million, down 12.78% from the prior year.
- EBT eased to -$13.1 million in Q1 2026 per CRVS's latest filing, from -$9.8 million in the prior quarter.
- Across five years, EBT topped out at $15.7 million in Q1 2025 and bottomed at -$39.5 million in Q3 2024.
- The 5-year median for EBT is -$6.1 million (2023), against an average of -$8.0 million.
- Across the five-year window, EBT plunged 669.91% in 2024 and jumped 364.98% in 2025, its largest moves.
- Year by year, EBT stood at -$5.8 million in 2022, then advanced by 0.8% to -$5.7 million in 2023, then tumbled by 589.72% to -$39.5 million in 2024, then soared by 75.13% to -$9.8 million in 2025, then tumbled by 33.14% to -$13.1 million in 2026.
- Per Business Quant, the three latest CRVS EBT figures stand at -$13.1 million (Q1 2026), -$9.8 million (Q3 2025), and -$7.6 million (Q2 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 259.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.49 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 541.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Corvus Pharmaceuticals | 1.23 Bn | 1.23 Bn | - | -13.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.09 Mn |
| Sep 30, 2025 | -9.83 Mn |
| Jun 30, 2025 | -7.61 Mn |
| Mar 31, 2025 | 15.73 Mn |
| Sep 30, 2024 | -39.54 Mn |
| Jun 30, 2024 | -3.69 Mn |
| Mar 31, 2024 | -5.94 Mn |
| Dec 31, 2023 | -5.73 Mn |
| Sep 30, 2023 | -5.14 Mn |
| Jun 30, 2023 | -5.22 Mn |
| Mar 31, 2023 | -6.14 Mn |
| Dec 31, 2022 | -5.78 Mn |
| Sep 30, 2022 | -12.68 Mn |
| Jun 30, 2022 | -7.35 Mn |
| Mar 31, 2022 | -7.84 Mn |
| Dec 31, 2021 | -7.22 Mn |
| Sep 30, 2021 | -9.47 Mn |
| Jun 30, 2021 | -11.70 Mn |
| Mar 31, 2021 | -11.89 Mn |
| Dec 31, 2020 | -10.25 Mn |